Last reviewed · How we verify
NCT05195970
Walnuts and Colon Health
NA trial testing Walnuts in Colorectal Cancer in 140 participants. Completed in 30 January 2026.
30 January 2026
Quick facts
| Lead sponsor | UConn Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 140 |
| Start date | 24 January 2022 |
| Primary completion | 30 January 2026 |
| Estimated completion | 30 January 2026 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Walnuts — full drug profile →
Conditions studied
- Colorectal Cancer — all drugs for Colorectal Cancer →
- Diet Habit — all drugs for Diet Habit →
Sponsor
UConn Health — full company profile →
Who can join
Adults 39 to 75, any sex, with Colorectal Cancer or Diet Habit. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research study is to examine whether adding walnuts to your diet can have a beneficial effect on the gut bacteria population, inflammatory markers in the blood, and the tissue that lines the inside of the colon.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Diet-driven microbiome changes and physical activity in cancer patients.
Ciernikova S, Sevcikova A, Stevurkova V, Mego M. · · 2023 · cited 11× · PMID 38075222 · DOI 10.3389/fnut.2023.1285516
Verify or expand the search:
- PubMed search for NCT05195970
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Walnuts
Trials testing the same drug.
- NCT06223672 — Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study · NA · recruiting
- NCT04918537 — Analysis of Microbiota Variations in Industry Workers Working Different Shifts and Impact of a Nutritional Intervention · NA · unknown
- NCT04066816 — Ellagic Acid, Urolithin and Colonic Microbial Communities Affected by Walnut Consumption · NA · completed
- NCT03334175 — Walnuts to Achieve Lasting NUTrition to Prevent Diabetes · Phase 1, PHASE2 · completed
- NCT03318042 — Genotype, Metabotype and Diet in a Cohort of Children and Adolescents From the Southeast of Spain. · NA · completed
Other recruiting trials for Colorectal Cancer
Currently open trials in the same condition.
- NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
- NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
- NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting
Other UConn Health trials
Trials by the same sponsor.
- NCT06115252 — Partnering to Enhance Emerging Adults' Response to Programs · NA · recruiting
- NCT04598074 — Opioid Package Prototype (OPP) · NA · not yet recruiting
- NCT06846853 — Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging) · Phase 4 · recruiting
- NCT06731764 — Novel Approaches to the Treatment of Hypothyroidism · Phase 2, PHASE3 · recruiting
- NCT06668194 — Effect of Force Magnitude on Canine Retraction and Gingival Crevicular Fluid Proteome · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05195970 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by UConn Health
- Last refreshed: 17 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05195970.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing